Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Stephanie Ford, MD

Stephanie Ford, MD

  • Specialty: Neonatology
  • Languages Spoken: English

Biography: Stephanie Ford, MD


  • Assistant Professor, CWRU School of Medicine

Certifications & Memberships

  • Neonatal/Perinatal Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics


Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - Uh Rainbow Babies And Children's Hospital (2013 - 2016)

Residency | Pediatrics
Pediatrics - Uh Rainbow Babies And Children's Hospital (2009 - 2013)

Medical Education
Case Western Reserve University School Of Medicine (2009)

Case Western Reserve University (2005)


Stephanie Ford, MD, earned her BA from Case Western Reserve University, with honors in Biochemistry, then her MD from the Case Western Reserve University School of Medicine. She then completed her pediatric residency and fellowship in Neonatal-Perinatal Medicine at University Hospitals Rainbow Babies & Children’s Hospital.

Dr. Ford is a physician scientist with appointments at UH Rainbow Babies & Children’s Hospital divisions of Neonatology and Pediatric Cardiology and Case Western Reserve University School of Medicine. Both her clinical and research interests center on the etiology and treatment of neonatal congenital heart diseases (CHDs). Dr. Ford’s research has been supported by the Congenital Heart Collaborative centered at UH Rainbow Babies & Children’s Hospital in Cleveland and Nationwide Children’s Hospital in Columbus, Ohio. Severe CHDs have an enormous impact on children and their families as there are seldom cures, only palliation, which carries significant morbidity and mortality. Dr. Ford’s position at UH Rainbow Babies & Children’s Hospital gives her the unique opportunity to tackle CHDs from the perspective of both a researcher and physician.

Dr. Ford has over 11 years of hands-on laboratory training in a broad range of laboratory techniques from her undergraduate, medical school, and fellowship training years. The last six years, her research has focused on optical pacing and ethanol exposure models of CHDs, with the goal of determining the underlying factors responsible for CDHs. She was the first to directly link abnormal blood flow measurements in vivo during early cardiogenesis to smaller endocardial cushions (primitive valves) and later CHDs. Her research determined that abnormal blood flow, without any outside surgical or drug exposure, can by itself have significant impact on the early tubular heart, leading to clinically significant CHDs. Dr. Ford is also investigating the effects of prenatal alcohol exposure on early cardiac blood flow and links to CHDs. She is exploring how prenatal alcohol exposure causes epigenetic changes, how epigenetics is related to CHDs, and how prenatal alcohol exposure-induced CHDs can be prevented with prenatal supplements. Her unique collaborations with the Biomedical Engineering Department at Case Western Reserve University allow her to connect diverse fields, linking embryonic blood flow to cardiac function, epigenetic changes, and subsequent 3-D structure of CHDs.

Research & Publications

Research Interests

Studies how functional changes in the embryonic heart lead to congenital heart disease and cardiac innervation

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Stephanie Ford did not disclose any Outside Relationships with Industry.